홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
GERN
#2376
Geron Corp
1.7
7
USD
+2.31%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+2.31%
월간 변동
+11.32%
6달 변화
+39.37%
년간 변동율
+35.11%
이전 종가
1.7
3
Open
1.7
7
Bid
Ask
Low
1.7
7
High
1.7
7
양
71
마켓
주식
헬스케어
GERN
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
318.53 M
323.73 M
508.72 M
546.06 M
636.9 M
640.54 M
—
Valuation ratios
Enterprise value
526.25 M
414.18 M
1.2 B
1.14 B
2.3 B
888.95 M
3.8 B
Price to earnings ratio
—
—
-6.49
-6.69
-13.11
-10.15
-39.99
Price to sales ratio
—
—
1 533.36
5 152.66
-1 339.75
—
—
Price to cash flow ratio
—
—
-7.17
-7.28
-10.46
-7.93
-25.05
Price to book ratio
—
—
11.42
4.93
8.16
3.9
6.51
EBITDA 비율에 대한 기업 가치
-6.55
-3.22
-8.42
-5.38
-8.2
-2.97
—
Profitability ratios
Return on assets %
-0.28
-0.51
-0.74
-0.47
-0.29
-0.15
-0.15
Return on equity %
-0.36
-0.92
-1.77
-0.74
-0.62
-0.37
-0.34
Return on invested capital %
-370.38
-500.89
-861.79
-727.02
-533.33
-95.12
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
-30.4 K
-8 183.7
-23.25 K
-81.83 K
10.18 K
—
—
EBITDA margin %
-29.94 K
-8 017.37
-23.19 K
-86.08 K
15.54 K
—
—
Net margin %
-29.89 K
-8 335.39
-23.81 K
-77.69 K
10.23 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
5.12
3.62
22.25
Current ratio
6.46
4.11
2.35
3.16
5.56
4.66
26.35
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
-0
0
—
Solvency ratios
Debt to assets ratio
0.11
0.24
0.18
0.1
0.2
0.21
0.86
Debt to equity ratio
0.14
0.43
0.42
0.15
0.43
0.54
1.94
Long term debt to total assets ratio
0.09
0.22
0.16
0.09
0.2
0.21
0.85
Long term debt to total equity ratio
0.11
0.39
0.38
0.14
0.42
0.53
1.91
Per share metrics
Operating cash flow per share
—
—
-0.33
-0.29
-0.34
-0.17
-0.17
EBIT per share
—
—
-0.36
-0.34
-0.39
-0.38
—
EBITDA per share
—
—
-0.36
-0.36
-0.41
-0.39
—
Total debt per share
—
—
0.09
0.07
0.19
0.18
0.73
Cash per share
—
—
0.45
0.58
0.63
0.12
0.48
Net current asset value per share
—
—
0.47
0.6
0.76
0.78
3.07
Tangible book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Working capital per share
—
—
0.27
0.41
0.62
0.61
2.58
Book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Geron Corporation
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
뉴스
Geron Corp, Barclays 헬스케어 컨퍼런스 발표: 성장 전략 및 향후 계획
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans
Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
게론, TD 카우en 컨퍼런스: 전략적 성장 및 시장 확대
Geron at TD Cowen: Strategic Growth and Market Expansion
Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)
Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
Geron Corp Q4 실적, 수익 에상치보다 저조
Geron earnings missed by $0.02, revenue fell short of estimates
Geron Corp, RYTELO 매출 모멘텀 유지할까?